chlorisondamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baudrie, V; Chaouloff, F | 1 |
Dedeoğlu, A; Fisher, LA | 1 |
Alper, RH | 1 |
3 other study(ies) available for chlorisondamine and 4-iodo-2,5-dimethoxyphenylisopropylamine
Article | Year |
---|---|
Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.
Topics: Adrenalectomy; Amidines; Amphetamines; Animals; Blood Glucose; Chlorisondamine; Dexamethasone; Drug Interactions; Hyperglycemia; Injections, Intravenous; Insulin; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1992 |
Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
Topics: Amidines; Amphetamines; Animals; Arginine Vasopressin; Behavior, Animal; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Chlorisondamine; Consciousness; Dose-Response Relationship, Drug; Injections, Intravenous; Injections, Intraventricular; Locomotion; Male; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists | 1991 |
Hemodynamic and renin responses to (+-)-DOI, a selective 5-HT2 receptor agonist, in conscious rats.
Topics: Amphetamines; Animals; Blood Pressure; Chlorisondamine; Heart Rate; Hemodynamics; Male; Prazosin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Regional Blood Flow; Renin | 1990 |